Pages that link to "Q30952463"

The following pages link to Humanization of the anti-CEA T84.66 antibody based on crystal structure data (Q30952463):

Displaying 23 items.

• Low Dose Focused Ultrasound Induces Enhanced Tumor Accumulation of Natural Killer Cells (Q30398870) (← links)
• Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies (Q33519052) (← links)
• Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas (Q33781006) (← links)
• Phylogenetic discordance of human and canine carcinoembryonic antigen (CEA, CEACAM) families, but striking identity of the CEA receptors will impact comparative oncology studies (Q33855456) (← links)
• Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging (Q34164704) (← links)
• Radioimmunoimaging of liver metastases with PET using a 64Cu-labeled CEA antibody in transgenic mice (Q34196254) (← links)
• Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein (Q35369090) (← links)
• Trial Watch: Monoclonal antibodies in cancer therapy (Q36038408) (← links)
• A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance (Q36610788) (← links)
• An efficient visualization tool for the analysis of protein mutation matrices (Q36665621) (← links)
• A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies (Q36908712) (← links)
• Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen. (Q37207310) (← links)
• Construction of humanized carcinoembryonic antigen specific single chain variable fragment and mitomycin conjugate (Q40061667) (← links)
• Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model. (Q46229896) (← links)
• Improving theranostics in pancreatic cancer (Q46466095) (← links)
• Engineering a high-affinity peptide binding site into the anti-CEA mAb M5A. (Q47578202) (← links)
• Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore. (Q47645403) (← links)
• Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions. (Q52639286) (← links)
• Physiologically-based modeling of the pharmacokinetics of "catch-and-release" anti-carcinoembryonic antigen monoclonal antibodies in colorectal cancer xenograft mouse models (Q57471664) (← links)
• Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model (Q60950317) (← links)
• Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor therapy and effects of stereotactic radiation (Q89966637) (← links)
• Improved antibody-guided surgery with a near-infrared dye on a pegylated linker for CEA-positive tumors (Q93119755) (← links)
• Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy (Q93128794) (← links)